Sign in
Taking people in United StatesNo phase

Abbott Cephea Mitral Valve Disease Registry

Key facts

Who runs it
Abbott Medical Devices
Where
Atlanta, Birmingham, Charleston, Charlotte, Chicago, Cleveland, Houston, Indianapolis, Minneapolis, Missoula, Murray, Nashville, Norfolk, Phoenix, Pittsburgh, Roslyn, The Bronx, Thousand Oaks, and Wichita, United StatesSee the 24 sites
Trial code
Status
Recruiting
People taking part
1,000 people, planned
Started
13 Aug 2025
Expected to end
Dec 2028
Type of study
Observational
Record updated
10 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Symptomatic mitral valve disease resulting in mitral regurgitation and/or severe mitral valve stenosis
  • New York Heart Association (NYHA) Functional Class II, III, or ambulatory IV
  • In the judgement of the Site Heart Team, transcatheter therapy is deemed to be more appropriate than conventional mitral valve surgery, TMVR is more likely to provide an optimal result than TEER, and the subject has been adequately treated per applicable standards, including for coronary artery disease, left ventricular dysfunction, and heart failure
  • Age 18 years or older at time of consent
  • The subject agrees to the study requirements, permits all follow-up data entry, and has provided written informed consent

Who cannot take part

  • Prior surgical or interventional treatment that interferes with the Cephea valve delivery or function
  • Subject is undergoing dialysis or experiencing chronic renal failure
  • Subject has chronic lung disease requiring continuous home oxygen therapy or chronic outpatient oral steroid use
  • Subjects with comorbidities that are likely to result in a life expectancy of less than 12 months
  • Pregnant or nursing subjects and those who plan pregnancy during the follow-up period

Where in United States

  • Emory University HospitalAtlanta, United StatesContact: Elizabeth Charles, MPHTaking people
  • Piedmont Heart InstituteAtlanta, United StatesContact: Danielle GriffithTaking people
  • University Hospital - Univ. of Alabama at Birmingham (UAB)Birmingham, United StatesContact: Katherine PhillipsTaking people
  • Medical University of South CarolinaCharleston, United StatesContact: Lauren WakefieldTaking people
  • Atrium Health - Carolinas Medical CenterCharlotte, United StatesContact: ShaMal BrownTaking people
  • Northwestern Memorial HospitalChicago, United StatesContact: Maggie McNamaraTaking people
  • The Cleveland Clinic FoundationCleveland, United StatesContact: Emilia DrenkhanTaking people
  • Houston MethodistHouston, United StatesContact: Laticia EllankilTaking people
  • UTHealth Memorial HermannHouston, United StatesContact: Angela ScottTaking people
  • Ascension St. VincentIndianapolis, United StatesContact: Jena Stanley, BSN, RN, CCRN-KTaking people
  • Minneapolis Heart InstituteMinneapolis, United StatesContact: Jennifer NguyenTaking people
  • Providence St. Patrick HospitalMissoula, United StatesContact: Hillary LaphamTaking people
  • Intermountain Medical CenterMurray, United StatesContact: Lindsay BoshTaking people
  • Ascension Saint ThomasNashville, United StatesContact: Sabrina KnightTaking people
  • TriStar Centennial Medical centerNashville, United StatesContact: Taegan VinarskyTaking people
  • Vanderbilt Heart & Vascular InstituteNashville, United StatesContact: Kathryn AdamsTaking people
  • Sentara Norfolk General HospitalNorfolk, United StatesContact: Christine Calayo, RNTaking people
  • Banner-University Medical Center PhoenixPhoenix, United StatesContact: Raelyn McGarryTaking people
  • Phoenix Cardiovascular Research GroupPhoenix, United StatesContact: Jessica ByrneTaking people
  • Allegheny General Hospital - ASRIPittsburgh, United StatesContact: Kaylea FlickTaking people
  • St. Francis HospitalRoslyn, United StatesContact: Elizabeth Haag, RN, BSN, CCRPTaking people
  • Montefiore Medical Center - Moses CampusThe Bronx, United StatesContact: Anna WielgatTaking people
  • Los Robles Regional Medical CenterThousand Oaks, United StatesContact: Jason YasharTaking people
  • Ascension Via Christi Hospitals WichitaWichita, United StatesContact: Lindsey SteeleTaking people

About the trial

What the trial wants to find out

The objective of this registry is to gather clinical data on symptomatic patients with mitral valve disease, including patients with mitral regurgitation, mitral stenosis, and mixed mitral valve disease. Data collected from this registry are expected to improve our understanding of the impact of correcting symptomatic mitral valve disease on clinical outcomes in patients that could be candidates for Transcatheter Mitral Valve Replacement and may also inform future regulatory or reimbursement submission strategies for the Cephea Mitral Valve System.

The group in the trial

  • Potential transcatheter mitral valve replacement (TMVR) candidates

    Patients with symptomatic mitral valve disease who may be candidates for transcatheter mitral valve replacement.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
10 September 2026